Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Non Operating Investment Income (2018 - 2020)

Historic Non Operating Investment Income for Abvc Biopharma (ABVC) over the last 3 years, with Q4 2020 value amounting to -$2317.0.

  • Abvc Biopharma's Non Operating Investment Income rose 9171.7% to -$2317.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$68562.0, marking a year-over-year increase of 8295.39%. This contributed to the annual value of -$339171.0 for FY2024, which is 5285.68% down from last year.
  • Per Abvc Biopharma's latest filing, its Non Operating Investment Income stood at -$2317.0 for Q4 2020, which was up 9171.7% from $665.0 recorded in Q3 2020.
  • In the past 5 years, Abvc Biopharma's Non Operating Investment Income ranged from a high of $665.0 in Q3 2020 and a low of -$201590.0 during Q3 2018
  • Moreover, its 3-year median value for Non Operating Investment Income was -$51813.0 (2019), whereas its average is -$66090.9.
  • Per our database at Business Quant, Abvc Biopharma's Non Operating Investment Income surged by 6791.06% in 2019 and then skyrocketed by 10102.8% in 2020.
  • Quarter analysis of 3 years shows Abvc Biopharma's Non Operating Investment Income stood at -$107963.0 in 2018, then skyrocketed by 74.09% to -$27973.0 in 2019, then soared by 91.72% to -$2317.0 in 2020.
  • Its Non Operating Investment Income stands at -$2317.0 for Q4 2020, versus $665.0 for Q3 2020 and -$38937.0 for Q2 2020.